Response to Weidhaas and Slack re: Comments on "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"
about
Response to Weidhaas and Slack re: Comments on "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Response to Weidhaas and Slack ...... lication for clinical testing"
@en
Response to Weidhaas and Slack ...... lication for clinical testing"
@nl
type
label
Response to Weidhaas and Slack ...... lication for clinical testing"
@en
Response to Weidhaas and Slack ...... lication for clinical testing"
@nl
prefLabel
Response to Weidhaas and Slack ...... lication for clinical testing"
@en
Response to Weidhaas and Slack ...... lication for clinical testing"
@nl
P2860
P1476
Response to Weidhaas and Slack ...... lication for clinical testing"
@en
P2093
Andrew Berchuck
Harvey A Risch
P2860
P356
10.1158/1078-0432.CCR-11-1504
P407
P577
2011-10-01T00:00:00Z